RE: Am in15 Sep 2024 17:11
Bojo
Totally it's a gamble either way at this point ,we will just have to see which way it goes . I have other options if I miss out and agl hit revenue or come up with some news .
There are two arguments as I see it ,people who are focused on the science and those that are focused on the business side of it . The contrast is huge when you look at them separately .
Countless review papers,studies and the start of some deals with big name clients . Co trast that to an sp near it's all time lows .
I've never doubted the science ,parsortix obviously works but it is a new market and still trying to gain traction and that has led to a lot of fund raises over the years . There have been changes of direction and delays,missed targets and a lot of news that was promised that didn't materialise . There was in talks with 20 plus companies that soon shrank due to lack of money for smaller customers,push back of ovarian and prostate sample testing etc .
That has all meant the SP has suffered so whilst the science works the. Numbers haven't resulting in cost cutting and raises etc
As I say it's a gamble on what events happen next and their impact on the SP. The chart looks pretty grim ATM so I'm happier being out for now . We should find out in a fortnight which way it goes .